Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
|
IL |
|
V
|
Veeva Systems Inc
SWB:VEE
|
US |
|
K
|
Kingspan Group PLC
DUS:KRX
|
IE |
|
Basic Fit NV
F:B4F
|
NL |
|
O
|
Opthea Ltd
NASDAQ:OPT
|
AU |
|
S
|
SAP SE
XMUN:SAP
|
DE |
|
Y
|
Yamana Gold Inc
XBER:RNY
|
CA |
|
A
|
Aegon NV
NYSE:AEG
|
NL |
|
D
|
Discovery Ltd
JSE:DSY
|
ZA |
|
N
|
Nasdaq Inc
XMUN:NAQ
|
US |
|
D
|
Diageo PLC
XETRA:GUI
|
UK |
|
B
|
Badger Meter Inc
SWB:33B
|
US |
|
C
|
Constellation Brands Inc
DUS:CB1A
|
US |
|
CF Bankshares Inc
NASDAQ:CFBK
|
US |
|
ING Groep NV
F:INN1
|
NL |
|
W
|
Wolters Kluwer NV
XMUN:WOSB
|
NL |
|
A
|
Alpha Services and Holdings SA
ATHEX:ALPHA
|
GR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TEVA's stock price target?
Not Available
TEVA does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Teva Pharmaceutical Industries Ltd?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 3 years is 2%.
What is the Operating Income forecast for Teva Pharmaceutical Industries Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 3 years is 11%.
What is the Net Income forecast for Teva Pharmaceutical Industries Ltd?
Projected CAGR
-69%
Over the last 13 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 3 years is -69%.
